Skip to content
    Virtue logo

    Virtue

    Austin, Texas, United StatesFounded 2021

    Virtue is the earliest-stage healthcare venture capital firm, backing elite pre-seed and seed founders building companies that radically transform the healthcare ecosystem. Founded in 2021 and based in Austin, Texas, the firm invests $500K–$4M initial checks exclusively in digital health and healthcare technology startups.

    55% of their portfolio is in Healthcare. Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Their most common stage is series-a (41% of deals). Average disclosed round size is $23.7M (across 19 rounds with reported amounts).

    Find people at Virtue on Goldilocks AI

    Portfolio

    18

    Fund Size

    $55.8M

    Top Stage

    Series A

    Last 12 Mo

    3

    Team

    SD

    Sean Doolan

    Principal

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    22 investments
    CompanyRoundAmountDate
    Solstice logoSolsticeSeries A$21MMay 2026
    Gyde logoGydeSeries C$60MJan 2026
    Prudentia Sciences logoPrudentia SciencesSeries A$20MJan 2026
    Translucent logoTranslucentSeries A$27MJan 2026
    Translucent AI logoTranslucent AISeries A$27MJan 2026
    Gyde logoGydeSeed$60MJan 2026
    LightSpun logoLightSpunSeries A—Sep 2025
    Solstice Health logoSolstice HealthSeed$3.5MFeb 2025
    Solstice logoSolsticeSeed$3.5MFeb 2025
    Seen Health logoSeen HealthSeries A$22MNov 2024
    Anna Health logoAnna HealthUnknown$9.3MNov 2024
    Tuva Health logoTuva HealthSeed$5MJan 2024
    Anna Health logoAnna HealthUnknown$9.3MJan 2024
    Evvy logoEvvySeries A—Sep 2023
    Synthetica Bio logoSynthetica BioSeed—Jun 2023
    Ryght AI logoRyght AISeed$3M—
    Zócalo Health logoZócalo HealthSeed$5M—
    Gyde logoGydeUnknown$60M—
    Anna logoAnnaUnknown$9.3M—
    IIntegral Privacy TechnologiesSeries A$25M—
    Gyde logoGydeUnknown$60M—
    Solstice Health logoSolstice HealthSeries A$21M—

    Top Co-Investors

    Last updated: 20 October 2026